Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Skyvit Powder
- Development stage
- Unknown
- Lead developer
- Skyways Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Skyvit Powder is a nutritional supplement developed and marketed by Skyways Healthcare. It is part of a branded generic pharmaceutical line distributed through a PCD (Proprietary-Customer-Distributor) franchise model. Formulated as a powder for oral administration, it is intended to supplement the diet with essential vitamins and minerals to address nutritional deficiencies and support general health and wellness. As a marketed generic formulation, it is not a novel drug candidate in clinical development but rather an established product in the Indian pharmaceutical distribution market.
- Brand names
- Skyvit Powder
- Other names
- Skyvit
Beyond the preview
Go deeper on Skyvit Powder.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Skyvit Powder.